The journey is as important as the destination

The Advanced Therapy Supply Chain is complex and made up of multiple moving parts. Watch this engaging webinar to hear real-world case studies that illustrate the challenges the sector is currently facing and discuss the approaches required to enable advanced therapy developers to build robust, commercial-scale, supply chains that enable patients to benefit from these life-changing therapies.

Hear from two leading experts – Simon Ellison and Kristen Franklin, Fisher BioServices – discussing the:

• Unique challenges that may be encountered when planning your logistics strategy for an allogeneic or autologous therapy.
• Importance of centralized control and communication throughout the supply chain.
• Potential impact of early planning on risk mitigation and cost of goods in clinical supply chain management.

Following the presentations, is a Q&A session including questions from our audience.

By registering to view this On Demand Webinar you are also signing up as a member of Cell & Gene Therapy Insights and agree to be contacted by Cell & Gene Therapy Insights’ sponsors. We will email you a username and password so you can read all our open access content.

Simon Ellison

Senior Manager, Advanced Therapies at

Simon is the Senior Manager, Advanced Therapies at Fisher BioServices. With the aim of building a supply chain solution that addresses the industries challenge of operations at commercial scale. Whilst at the Cell and Gene Therapy Catapult Simon identified the need for, and built the Seamless Freight portfolio. He also helped develop the commercial operating model for the Catapult Manufacturing Centre that resulted in the first collaborators entering, and the start of a cluster forming around this unique facility.
Prior to this Simon was the Head of Commercial at NHS Blood and Transplant (NHSBT) where he merged the needs of the industry with NHSBTs manufacturing capability. This enabled multiple UK and International organisations to move their therapies forwards.

Kristen Franklin

Client Services Manager, Cell Therapy at Thermo Fisher Scientific

Kristen is the Client Services Manager for Cell Therapy projects at Fisher BioServices. In her current role, Kristen manages a team of Project Managers who interact with clients to provide logistic and strategic support for cell therapy clinical trials, as well as commercialization operations. Kristen’s background is in process development and manufacturing of biologics, as well as project management. She holds a Master’s degree from the University of Maryland in Biotechnology Management.

Watch now

SPEAKERS

Simon Ellison

Senior Manager, Advanced Therapies at

Kristen Franklin

Client Services Manager, Cell Therapy at Thermo Fisher Scientific

You might also like

Mastering the journey from initial method transfer to successful lot release for cell & gene therapies

A Chang, H Malicki, J Cheung et al.

6 June

Watch

Positioning early cell therapy programs for clinical success: insights to mitigate risk and ensure GMP readiness

K Watanabe, M Sadik, M Duggan

7 March

Watch

Quadplex dPCR as a tool to analyze genome integrity and heterogeneity in gene therapy drug products

Ryan Massopust

11 June

Watch

When does outsourcing autologous collection center qualification and the cell therapy supply chain make sense?

A Hines, J Newman, M van Houten

14 November

Watch

Optimizing access to high quality, standardized, and compliant leukopaks for the development and commercialization of allogeneic therapies

Makensie Becker

18 April

Watch